Nearly all patients with Parkinson’s disease (PD) experience non-motor symptoms at some stage of the disease. Psychiatric symptoms are the most frequent non-motor symptoms, reported by approximately two-thirds of patients with PD. In this slide deck, quality of life and the comorbidities of PD are discussed. This includes insights into the prevalence of psychosis and neurogenic orthostatic hypotension in patients with PD.

This slide deck has been developed in collaboration with the former Lundbeck International Neuroscience Foundation.

Index for
slide deck

Introduction

Non-Motor Symptom Complex and Comorbidities
Non-Motor Symptom Complex and Comorbidities

Nearly all patients with Parkinson’s disease experience non-motor symptoms at some stage of the disease. Psychiatric symptoms are the most frequent non-motor symptoms, reported by approximately two-thirds of patients with PD.

file_download Download slide in HQ
Non-motor symptom complex of Parkinson’s disease
Non-motor symptom complex of Parkinson’s disease

Nearly all patients with Parkinson’s disease (PD) experience non-motor symptoms at some stage of the disease.[Goldman & Holden, 2014] Psychiatric symptoms are the most frequent non-motor symptoms, reported by approximately two-thirds of patients with PD.[Goldman & Holden,…

file_download Download slide in HQ
Commonly experienced non-motor symptoms of Parkinson’s disease
Commonly experienced non-motor symptoms of Parkinson’s disease

The non-motor symptoms of PD can be grouped into four domains: autonomic (including gastrointestinal, genitourinary, and cardiovascular symptoms), sleep disorders; neuropsychiatric disorders; and sensory and other symptoms (including pain and fatigue).[Erro et al., 2015; …

file_download Download slide in HQ
The impact of non-motor symptoms on quality of life
The impact of non-motor symptoms on quality of life

One of the main principles of caring for patients with PD is to preserve quality of life as much as possible, particularly during the later stages of the disease.[Prakash et al., 2016] Historically, the focus of clinical care has been on control of motor symptoms but, mor…

file_download Download slide in HQ

Cognitive symptoms of Parkinson’s disease

Cognitive symptoms of Parkinson’s disease
Cognitive symptoms of Parkinson’s disease
file_download Download slide in HQ
Cognition and cognitive impairment in Parkinson’s disease
Cognition and cognitive impairment in Parkinson’s disease

Although the neuropathology underlying cognitive impairments in PD broadly conforms to what is termed a ‘subcortical’ syndrome, there is considerable inter-patient heterogeneity.[Fields, 2017] This variation has led to the suggestion that patients with PD and cognitive im…

file_download Download slide in HQ
MDS diagnostic criteria for MCI in Parkinson’s disease
MDS diagnostic criteria for MCI in Parkinson’s disease

The MDS diagnostic criteria for MCI in PD represent an attempt to harmonise the various definitions of MCI in PD that have been used in the past.[Litvan et al., 2012] A uniform definition allows identification of:[Litvan et al., 2012]

  • the clinical characteristics of the…
file_download Download slide in HQ
Prevalence of MCI in patients with Parkinson’s disease
Prevalence of MCI in patients with Parkinson’s disease

One of the problems that researchers have when studying impaired cognition in PD is the wide variation in criteria used to define MCI, which can make comparisons between studies challenging.[Aarsland et al., 2010; Meireles & Massano, 2012]
One study managed to harmonise d…

file_download Download slide in HQ
Diagnostic criteria for dementia in Parkinson’s disease
Diagnostic criteria for dementia in Parkinson’s disease

While developing the new guidelines for diagnosis of dementia in PD, the MDS task force conducted a comprehensive and systematic review of studies in this area.[Emre et al., 2007] The task force examined every aspect of dementia that occurs over the course of PD, includin…

file_download Download slide in HQ
Management of cognitive symptoms in Parkinson’s disease
Management of cognitive symptoms in Parkinson’s disease

The risk factors for PD dementia can be grouped into clinical, molecular, and structural/functional imaging risk factors – as depicted on slide.[Aarsland et al., 2017]

Several potential therapies and interventions have been proposed or researched to tackle the cognitive s…

file_download Download slide in HQ
Cognitive impairment specifically contributes to poorer quality of life, even in early Parkinson’s disease
Cognitive impairment specifically contributes to poorer quality of life, even in early Parkinson’s disease

Reference used on slide:
Lawson RA, Yarnall AJ, Duncan GW, et al. Severity of mild cognitive impairment in early Parkinson’s disease contributes to poorer quality of life. Parkinsonism Relat Disord 2014; 20 (10): 1071–1075.

file_download Download slide in HQ

Related content

Dopamine in Parkinson’s Disease and Schizophrenia play_circle Video play_circle
Dopamine in Parkinson’s Disease and Schizophrenia

Professors Shen-Yang Lim and Christoph Correll explore dopamine’s role in Parkinson’s disease and schizophrenia, discussing treatment evolution, side effects, and parallels between the disorders. Access more resources at Neurotorium.org.

04.12.2024 Parkinson’s Disease
image Image
Parkinson’s Disease and Braak stages

The Braak staging scheme is a valuable model for conceptualizing PD progression and categorizes PD into stages of neuropathological changes.

11.04.2024 Parkinson’s Disease
image Image Non-motor symptoms within Parkinsons disease
Non-motor symptoms in Parkinson’s Disease

This infographic provides a visual, at-a-glance overview of the Non-motor symptoms in Parkinson’s Disease.

30.06.2023 Parkinson’s Disease